Generic incruse?

Short answer: No widely available generic version of Incruse (umeclidinium bromide) in the U.S. right now.

What that means:
- Incruse Ellipta = umeclidinium bromide, a long-acting muscarinic antagonist (LAMA) for COPD maintenance.
- As of today, there isn’t an FDA-approved generic umeclidinium inhaler in the U.S. The brand name remains Incruse Ellipta.
- Some other countries may have different availability; patent and device protections can delay generics.

If you’re hoping to save money:
- Talk with your pharmacist or prescriber about alternatives. Other COPD LAMA options (and some with generics) may be available, such as tiotropium-containing products, depending on your country.
- Your clinician can help determine if a different inhaler or therapy could be appropriate for you.

If you’d like, tell me your country or region and I can check the current generic status there or look into cost-saving options. Also, I can provide quick usage and safety notes for umeclidinium if that would help.